BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions

  The German pharmaceutical giant is the latest pharma company to challenge the constitutionality of the Inflation Reduction Act’s drug price negotiation program.

  August 22, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Employer Resources

  Report: Recruitment Market Update, 2022 Q3

  Get up to speed with BioSpace’s data with up-to-date info about retention, layoffs, “quiet quitting” and projections for 2023.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Employer Resources

  Report: State of the Recruitment Market, 2023

  After a tumultuous 2022, life science employers are settling into their hiring goals for 2023. Though they may be hiring at lower volume, the majority of organizations are still actively recruiting.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Industry Ties to Patient Advocacy Board Members, Execs Raise Concerns

  Nearly three-quarters of the highest-revenue U.S. patient advocacy organizations have board members or senior leadership with ties to the pharma or medical device industries, finds study.

  August 22, 2023

   · 

  2 min read

   · 

  Nick Paul Taylor
• 

  Employer Resources

  Report: State of the Recruitment Market, 2022

  BioSpace surveyed industry employers and professionals to understand what to expect from the recruitment market in 2022. What do professionals want? How difficult will it be to recruit new talent?

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Policy

  Teva to Pay $225M in DOJ Generic Drug Price-Fixing Settlement

  Three years after the initial case, Teva Pharmaceuticals is finally settling its drug price-fixing charges with the Department of Justice for $225 million, payable over a five-year period.

  August 22, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Employer Resources

  Report: Connecting the Dots: DEI Strategies & Benchmarking

  In the final instalment of our Diversity in Life Sciences series, BioSpace provides life sciences organizations with practical solutions and benchmarking data to strengthen their DEI initiatives.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Employer Resources

  Report: U.S. Life Sciences 2020 Diversity & Inclusion

  In the 2020 US Life Sciences Diversity & Inclusion report, BioSpace dives into how different segments of employees experience and perceive policies, attitudes and actions. Our data suggests that there are significant disparities between segments.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Employer Resources

  Report: Women in Life Sciences

  Over the last two decades, women have achieved near equal levels of representation in life sciences - though there are distinct gaps in leadership and pay equity. The experience of women also differs vastly depending on age, race, and other factors.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights
• 

  Employer Resources

  Report: The Black Employee Experience

  How does being Black affect the workplace experience as a life sciences professional? BioSpace surveyed our community to gain a greater understanding of Black employees’ feelings of inclusion and their perspectives on employer DEI initiatives.

  August 22, 2023

   · 

  1 min read

   · 

  BioSpace Insights